Oxford’s Covid-19 Vaccine Blazes Trail for Oncolytic Virus Firms
Since the debut of Imlygic in 2015, no other oncolytic virus cancer therapies have been…
Since the debut of Imlygic in 2015, no other oncolytic virus cancer therapies have been…
A colossal deal struck last month between Germany’s Merck KGaA and UK-based Artios Pharma is…
The end of 2020 saw several big pharma acquisitions of companies developing antibody-drug conjugate drugs…
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
Over the last decade, oncology drug development has been marred by the high attrition rates…
The newly founded SynOx has become the latest startup to attack solid tumors via their…
Last week’s €1.75B deal between the German biotech Affimed and Swiss giant Roivant backs up…
Today, the global immunotherapy drugs market is valued at €139B ($163B) and is estimated to…
After decades of neglect from big pharma, radiopharmaceuticals are generating major oncology deals globally. This…
The French big pharma Sanofi has offered €308M to acquire the Dutch firm Kiadis Pharma…
In the past few months, we’ve seen major fundraises and partnerships from European biotechs that…
Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come…